NOS3 and melanoma: To investigate if the overexpression of Nos3 in 4C11+ metastatic melanoma cells was associated with its dysfunction and the altered redox status observed in these cells, Nos3 was knocked down in 4C11+ melanoma cells using an eNOS shRNA.